Abstract
Purpose: To compare two GnRHa flare protocols among poor responders undergoing IVF-ET and to evaluate if a Day 6 estradiol level can predict outcome.
Methods: Retrospective analyses of GnRHa flare IVF cycles among poor responders. Group A (“miniflare,” N = 36) 40 μg GnRHa s.c. b.i.d. from Day 3; Group B (“standard flare,” N = 24) 1 mg GnRHa on Days 2–3; 0.5 mg GnRHa from Day 4. ROC analysis was performed to find a Day 6 estradiol value that is predictive of cycle outcome.
Results: With the standard flare, patients required less gonadotropins and tended to have fewer cancellations and higher pregnancy rates. A Day 6 estradiol level ≤75 pg/mL was predictive of cycle cancellation, but not of pregnancy outcome.
Conclusions: Standard GnRHa flare offers some advantages over the miniflare. Day 6 estradiol ≤75 pg/mL is predictive of cycle cancellation. When the estradiol level is low on Day 6 (no flare), early cancellation should be considered.
Keywords: Cycle cancellation, GnRHa flare, IVF-ET, poor responder, pregnancy
Full Text
The Full Text of this article is available as a PDF (53.7 KB).
REFERENCES
- 1.Faber BM, Mayer J, Cox B, Jones D, Toner JP, Oehninger S, Muasher S. Cessation of gonadotropin releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril. 1998;69:826–830. doi: 10.1016/s0015-0282(98)00040-5. [DOI] [PubMed] [Google Scholar]
- 2.Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73:667–676. doi: 10.1016/s0015-0282(99)00630-5. [DOI] [PubMed] [Google Scholar]
- 3.Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril. 1998;69:419–424. doi: 10.1016/s0015-0282(97)00575-x. [DOI] [PubMed] [Google Scholar]
- 4.Frydman R, Forman R, Belaisch-Allart J, Hazout A, Parneix I, Testart J. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program. Fertil Steril. 1988;50:471–475. doi: 10.1016/s0015-0282(16)60135-8. [DOI] [PubMed] [Google Scholar]
- 5.Cramer DW, Powers DR, Oskowitz SP, Liberman RF, Hornstein MD, McShane PM, Barbieri RL. Gonadotropinreleasing hormone agonist use in assisted reproduction cycles: The influence of long and short regimens on pregnancy rates. Fertil Steril. 1999;72:83–90. doi: 10.1016/s0015-0282(99)00187-9. [DOI] [PubMed] [Google Scholar]
- 6.Padilla SL, Bayati J, Garcia JE. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril. 1990;53:288–294. doi: 10.1016/s0015-0282(16)53283-x. [DOI] [PubMed] [Google Scholar]
- 7.Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ. The gonadotropin-releasing hormone agonist stimulation test-a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril. 1991;56:711–717. doi: 10.1016/s0015-0282(16)54604-4. [DOI] [PubMed] [Google Scholar]
- 8.Hu Y, Maxson WS, Hoffman DI, Ory SJ, Eager S, Dupre J, Lu C. Maximizing pregnancy rates and limiting higher-order multiple conceptions by determining the optimal number of embryos to transfer based on quality. Fertil Steril. 1998;69:650–654. doi: 10.1016/s0015-0282(98)00024-7. [DOI] [PubMed] [Google Scholar]
- 9.Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N. Limited success using the “flare” protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril. 1997;67:900–903. doi: 10.1016/s0015-0282(97)81403-3. [DOI] [PubMed] [Google Scholar]
- 10.Toth TL, Awward JT, Veeck LL, Jones HW, Muasher SJ. Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med. 1996;41:321–326. [PubMed] [Google Scholar]
- 11.Salat-Baroux J, Rotten D, Alvarez S, Antoine JM. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation. Fertil Steril. 1993;60:791–799. doi: 10.1016/s0015-0282(16)56278-5. [DOI] [PubMed] [Google Scholar]
- 12.Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, Fernandez H, Frydman F. A protocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3. Hum Reprod. 1996;11:1169–1172. doi: 10.1093/oxfordjournals.humrep.a019348. [DOI] [PubMed] [Google Scholar]
- 13.Broekmans FJ, Scheffer GJ, Bancsi LFJMM, Dorland M, Blankenstein MA, te Velde ER. Ovarian reserve tests in infertility practice and normal fertile women. Maturitas. 1998;30:205–214. doi: 10.1016/s0378-5122(98)00075-9. [DOI] [PubMed] [Google Scholar]
- 14.Sharara FD, Scott RT, Jr, Seifer DB. The detection of diminished ovarian reserve in infertile women. AmJ Obstet Gynecol. 1998;179:804–812. doi: 10.1016/s0002-9378(98)70087-0. [DOI] [PubMed] [Google Scholar]
- 15.Lindheim SR, Barad DH, Witt BR, Ditkoff E, Sauer MV. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet. 1996;13:745–747. doi: 10.1007/BF02066431. [DOI] [PubMed] [Google Scholar]
- 16.Kovacs P, Barg PE, Witt BR. Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet. 2001;18:391–394. doi: 10.1023/A:1016626607387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril. 1997;67:93–97. doi: 10.1016/s0015-0282(97)81862-6. [DOI] [PubMed] [Google Scholar]
- 18.Loumaye E, Vankrieken L, Depreester S, Psalti I, de Cooman S, Thomas K. Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. Fertil Steril. 1989;51:105–111. doi: 10.1016/s0015-0282(16)60437-5. [DOI] [PubMed] [Google Scholar]